A 39-year-old, left-handed woman with right temporal lobe epilepsy was admitted for an intracarotid sodium amobarbital procedure (Wada test) to establish language and memory representation of each hemisphere and hence determine if she was suitable for a right anterior temporal lobectomy. This procedure involves catheterization of a carotid artery in a first session (and the other in another session) via the femoral artery before amobarbital injection and, therefore, includes an angiogram of the carotid vasculature using a contrast agent. Following left intracarotid injection of iopamidol contrast agent, she manifested a rapid decrease in consciousness and progressive right hemiplegia, requiring intubation and admission to the intensive care unit. Continuous electroencephalogram monitoring showed severe left hemispheric slowing. Initial brain magnetic resonance imaging (MRI) showed left hemispheric edema suggestive of iodinated contrast encephalopathy (Figure 1 ). Her level of consciousness and motor strength markedly improved within 2 weeks and neuropsychological deficits resolved over the following months. A repeat neuropsychological evaluation 15 months later showed significant improvement of cognitive function, albeit with some mild language deficits and psychomotor slowing. Serial followups over the next 2 years revealed gradual regression of the MRI abnormalities (Figure 2) . Iodinated contrast encephalopathy is an uncommon, usually self-limiting and reversible complication after angiography.
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Iodinated contrast encephalopathy is an uncommon, usually self-limiting and reversible complication after angiography. [1] [2] [3] [4] The mechanism of neurotoxicity is thought to be a temporary disruption of the blood-brain barrier by the iodinated contrast and parenchymal inflammation. 2, 3 The most frequent clinical presentations are transient cortical blindness, seizures, cognitive dysfunctions, and focal neurological deficits including sensorimotor impairments.
2 Although severe and long-lasting in our patient, most reported cases have lasted less than 2 to 3 hours. 1 Risk factors for iodinated contrast encephalopathy include hypertension and renal failure. 2, 3 Common neuroimaging findings are contrast enhancement and oedema of the cortex, which can be found in up to 54% of computed tomography scans performed within 2 hours of the event. 2 Brain MRI scans more frequently reveal a pattern of focal or diffuse cortical T2-weighted fluid-attenuated inversion recovery hyperintensity involving the ipsilateral hemisphere. 2, 5, 6 Management includes exclusion of a thromboembolic event because of catheterization, early recognition, careful observation, and monitoring until self-resolution.
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